Clinical Trial Update: Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous) [NA]

View source ↗

Summary

A pilot trial comparing subcutaneous versus transvenous implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy, which has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Ventricular Arrhythmia

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Implantable Defibrillator User, Hypertrophic Cardiomyopathy | NA | Status: COMPLETED